Use of lidocaine and procaine in patients with pheochromocytoma.
D000328:Adult; D000772:Anesthesia, Local; D001145:Arrhythmias, Cardiac / Q000517:prevention & control; D001810:Blood Volume; D002395:Catecholamines / Q000652:urine; D004562:Electrocardiography; D004569:Electroencephalography; D005260:Female; D006221:Halothane; D006339:Heart Rate / Q000187:drug effects; D006801:Humans; D006973:Hypertension / Q000517:prevention & control; D007022:Hypotension / Q000517:prevention & control; D007275:Injections, Intravenous; D008012:Lidocaine; D008297:Male; D008614:Meperidine; D008875:Middle Aged; D009609:Nitrous Oxide; D010643:Phenoxybenzamine / Q000627:therapeutic use; D010646:Phentolamine / Q000032:analysis / Q000627:therapeutic use; D010673:Pheochromocytoma / Q000601:surgery*; D011343:Procaine; D013390:Succinylcholine; D013874:Thiopental; D014642:Vanilmandelic Acid / Q000652:urine; D014662:Vasoconstrictor Agents / Q000627:therapeutic use
D002395:Catecholamines; D014662:Vasoconstrictor Agents; D010643:Phenoxybenzamine; D011343:Procaine; D014642:Vanilmandelic Acid; D008012:Lidocaine; D008614:Meperidine; D013390:Succinylcholine; D013874:Thiopental; D009609:Nitrous Oxide; D006221:Halothane; D010646:Phentolamine